Jan 06, 2020
United Therapeutics Corporation To Present At The 38th Annual J.P. Morgan Healthcare Conference
Dec 19, 2019
CollPlant Publishes Letter to Shareholders
Oct 23, 2019
United Therapeutics Corporation to Report Third Quarter 2019 Financial Results Before the Market Opens on Wednesday, October 30, 2019
Oct 21, 2019
United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study
Oct 18, 2019
Persistent Pulmonary Hypertension of the Newborn Pipeline Insights 2019 Featuring United Therapeutics, Mallinckrodt, Proteo Biotech, Beyond Air, Farmacon-IL, Merck Sharp & Dohme
Sep 12, 2019
Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application
Sep 11, 2019
United Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application For Review
Jun 26, 2019
Orenitram (treprostinil; United Therapeutics) Market Overview - Newer Brand Uptravi (selexipag; Johnson & Johnson/Nippon Shinyaku) Poses Tough Competition in the Oral Prostacyclin Class
Jun 26, 2019
Remodulin (treprostinil; United Therapeutics/Mochida) Overview: United Therapeutics is Developing Three New Formulations of Remodulin to Overcome Administration Difficulties
Jun 20, 2019
CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business
Jun 05, 2019
United Therapeutics Corporation to Present at Goldman Sachs 40th Annual Global Healthcare Conference
May 29, 2019
The global pulmonary arterial hypertension market size is expected to reach USD 9.3 billion by 2026
May 28, 2019
United Therapeutics Corporation To Present at Jefferies 2019 Healthcare Conference
May 07, 2019
United Therapeutics And DEKA Announce FDA Clearance Of The Unity Subcutaneous Delivery System For Remodulin®
Apr 29, 2019
United Therapeutics Announces FDA Approval Of XPS(TM) And Steen Solution(TM) Used To Perform Centralized Ex-Vivo Lung Perfusion Services
Apr 24, 2019
United Therapeutics Corporation To Report First Quarter 2019 Financial Results Before The Market Opens On Wednesday, May 1, 2019
Apr 23, 2019
CollPlant to Present at ThinkEquity Conference on May 2, 2019 in New York City
Apr 17, 2019
United Therapeutics Issues Statement In Response To Meritless Lawsuit
Apr 08, 2019
United Therapeutics Announces BEAT Study of Esuberaprost Does Not Meet Primary Endpoint
Mar 04, 2019
United Therapeutics Corporation To Present At Cowen And Company 39th Annual Health Care Conference